Consolidated Statements of Operations - USD ($)	3 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	[1]
Consolidated Statements of Operations
Revenues	$ 3,513,487	$ 3,615,556
Cost of expenses:
Cost of revenues	2,239,299	1,681,774
Research and development expenses	154,666	227,480
Selling, general, and administrative expenses	2,220,828	1,818,534
Total costs and expenses	4,614,793	3,727,788
Loss from operations	(1,101,306)	(112,232)
Interest expense - related party	65,713	41,400
Loss before income taxes	(1,167,019)	(153,632)
Provision/(benefit) for income taxes	0	(103,065)
Net loss	$ (1,167,019)	$ (50,567)
Net loss per common share - basic	$ (0.15)	$ (0.01)
Net loss per common share - diluted	$ (0.15)	$ (0.01)
Weighted average number of common shares outstanding - basic	7,696,091	7,690,199
Weighted average number of common shares outstanding - diluted	7,696,091	7,690,199

[1] Certain January 31, 2017 balances have been restated from previously reported results. Please refer to Note 2 of the Company’s Annual Report on Form 10-K for the year ended October 31, 2017